Nanotechnology Based Approaches for Tuberculosis Treatment 2020
DOI: 10.1016/b978-0-12-819811-7.00003-5
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 75 publications
0
4
0
Order By: Relevance
“…The development of therapies based on nanomaterials holds promise for treating bacterial infections that are challenging to treat, as they may be able to overcome existing pathways associated with acquired drug resistance ( Khorsandi et al, 2021 ). Furthermore, because of their unique size and physical makeup, nanoparticles can target biofilms and treat infections that are resistant to conventional antibiotics ( Eduardo Pérez-Martínez and Zenteno-Cuevas, 2020 ). Finally, we recommend additional research to seek long-term solutions for MDR and XDR infection prevention and management.…”
Section: Future Prospective For Management Of Mdr and Xdr Infection/s...mentioning
confidence: 99%
“…The development of therapies based on nanomaterials holds promise for treating bacterial infections that are challenging to treat, as they may be able to overcome existing pathways associated with acquired drug resistance ( Khorsandi et al, 2021 ). Furthermore, because of their unique size and physical makeup, nanoparticles can target biofilms and treat infections that are resistant to conventional antibiotics ( Eduardo Pérez-Martínez and Zenteno-Cuevas, 2020 ). Finally, we recommend additional research to seek long-term solutions for MDR and XDR infection prevention and management.…”
Section: Future Prospective For Management Of Mdr and Xdr Infection/s...mentioning
confidence: 99%
“…This global plan is framed in the United Nation Sustainable Development Goals, and establishes the goal to end with the TB as an epidemic disease for 2030, to reduce the deaths by 90% and the number of new cases per 100 000 inhabitants per year worldwide. To achieve these goals it has been recognized that it is essential to increase research and technological development in TB, prioritizing the generation of new vaccines (9,10), shorter and more effective treatment schemes for latent tuberculosis, to identify novel mehcanisms of drug administration (11), as well as the development of rapid diagnostic tests for diagnostic of drug resistance (1).…”
Section: New Molecular Mechanisms Related To Drug Resistance In Tuber...mentioning
confidence: 99%
“…These come with some limitations, such as giving false-positive results 8 . However, there are currently no biosensing diagnostic devices available for MDR-TB detection [9][10][11] . In addition, there are no optical-based biosensors that have been developed, commercially, for the detection of multi-drug resistant TB mutations 12,13 .…”
Section: Introductionmentioning
confidence: 99%
“…Biosensing devices have been used in various aspects of drug discovery and development, diagnostics, monitoring and management of diseases, the environment, and water quality 11,14 . In essence, biosensing devices are analytical devices used for sensitive, fast, and real-time monitoring and detection of biological molecules.…”
Section: Introductionmentioning
confidence: 99%